Selection of a Suitable Patient Population for New Antiplatelet Therapy From the Large Clinical Trial Database of the Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events-Thrombolysis in Myocardial Infarction 50 (TRA-2P-TIMI50) Trial

Circulation. 2015 Mar 24;131(12):1041-3. doi: 10.1161/CIRCULATIONAHA.115.015471. Epub 2015 Feb 13.

Abstract

No abstract available

Keywords: Editorials; blood platelets; platelet aggregation inhibitors.

Publication types

  • Editorial
  • Comment

MeSH terms

  • Diabetes Mellitus / drug therapy*
  • Female
  • Humans
  • Lactones / therapeutic use*
  • Male
  • Myocardial Infarction / drug therapy*
  • Pyridines / therapeutic use*
  • Receptors, Thrombin / antagonists & inhibitors*
  • Secondary Prevention / trends*
  • Stroke / prevention & control*
  • Thrombosis / prevention & control*

Substances

  • Lactones
  • Pyridines
  • Receptors, Thrombin
  • vorapaxar